Viewing Study NCT05182658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-01-05 @ 2:49 PM
Study NCT ID: NCT05182658
Status: UNKNOWN
Last Update Posted: 2023-10-26
First Post: 2021-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Empagliflozin in Hypertrophic Cardiomyopathy
Sponsor: National Institute of Cardiology, Warsaw, Poland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertrophic Cardiomyopathy View
None Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypertrophic cardiomyopathy View
None Heart Failue View
None Empagliflozin View
None Sodium-glucose transport protein 2 inhibitor View
None SGLT2 inhibitor View